First Marijuana, Then Peptides. Why Psychedelics Are Wall Street's Next Big Trip.

Definium Therapeutics advances the case for medical LSD after reporting positive late-stage trial data for its experimental drug, DT120.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。